Nicole Chevalier
Surgical · Hartford, CTNPI 1861863607
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.7% of the total across 432 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by AbbVie at 29.2% of the total. Among surgical clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 432 payments — averaging $22.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- UCB, Inc.$1K
- LEO Pharma Inc.$755
- Amgen$737
- Incyte Corporation$716
- Johnson & Johnson$524
- plus $3K from 18 others
What the payments were for
- Consulting fees$6006%
- Food & beverage$8,78191%
- Education$3043%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 115 | $2,828 |
| UCB, Inc. | 78 | $1,277 |
| LEO Pharma Inc. | 36 | $755 |
| Amgen | 46 | $737 |
| Incyte Corporation | 37 | $716 |
| Johnson & Johnson | 21 | $524 |
| E.r. Squibb & Sons, L.L.C. | 22 | $355 |
| Pfizer | 15 | $318 |
| Regeneron Healthcare Solutions, Inc. | 8 | $305 |
| Revance Therapeutics, Inc. | 7 | $254 |
| Lilly USA, LLC | 9 | $210 |
| Novartis | 6 | $193 |
| Arcutis Biotherapeutics, Inc. | 2 | $192 |
| Merz North America, Inc. | 1 | $192 |
| Sanofi | 5 | $177 |
| Sun Pharmaceutical Industries Inc. | 7 | $158 |
| VYNE Pharmaceuticals Inc. | 1 | $125 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $91 |
| Almirall LLC | 4 | $74 |
| Biofrontera Inc. | 4 | $57 |
| Dermavant Sciences, Inc. | 2 | $53 |
| Galderma Laboratories, L.p. | 2 | $52 |
| Organon | 2 | $23 |
| LNHC, Inc | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,684 in reported general payments places this provider in the 95th percentile of 568 surgical providers in Connecticut.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 52 | $308,585 |
| RinvoqUpadacitinib | 16 | $115,721 |
| OpzeluraRuxolitinib Phosphate | 24 | $58,339 |
| ZoryveRoflumilast | 20 | $17,451 |
| Pimecrolimus | 21 | $7,370 |
| Clobetasol Propionate | 62 | $3,112 |
| Ketoconazole | 88 | $2,790 |
| Doxycycline Hyclate | 44 | $2,176 |
| Azelaic Acid | 17 | $1,720 |
| Betamethasone Dipropionate | 23 | $1,467 |
| Tretinoin | 23 | $1,436 |
| Mometasone Furoate | 45 | $988 |
| ErythromycinErythromycin Base In Ethanol | 42 | $868 |
| Fluocinolone AcetonideFluocinolone/Shower Cap | 12 | $791 |
| Fluorouracil | 19 | $770 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRinvoq | $2,828 | $115,72116 claims |
| Incyte CorporationOpzelura | $716 | $58,33924 claims |
| Arcutis Biotherapeutics, Inc.Zoryve | $192 | $17,45120 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 568 surgical providers in Connecticut.
Other surgical in Hartford
- Nicole HooverHartford$9K
- Chandranni QuinonesHartford$6K
- Juliana SpagnuoloHartford$5K
- Emily VassorHartford$4K
- Brianna GawishHartford$4K
- Kevin FitzsimmonsHartford$4K
- Elchanan OrlanskyHartford$4K
- Lisa RinaldiHartford$3K
- James RoyHartford$2K
- Erin Myers AlbaridiNorwalk$70K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.